Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 4/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.59 |
| ▸ | GLA | P06280 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | TNKS2 | Q9H2K2 | 8/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | TNKS | O95271 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL74712 | 1.00 | AR (0.65) | ARKDM4EGLAGAAALDH1A1 | |
| SCHEMBL28067946 | 0.86 | CA12 (0.53) | ARKDM4EGLAGAAALDH1A1 | |
| SCHEMBL1394900 | 0.83 | AR (0.58) | ARKDM4EGLAGAAALDH1A1 | |
| SCHEMBL2268508 | 0.83 | AR (0.61) | ARKDM4EGLAGAAALDH1A1 | |
| SCHEMBL29402764 | 0.81 | AR (0.69) | ARKDM4EGLAGAAALDH1A1 | |
| SCHEMBL22501754 | 0.81 | AR (0.69) | ARKDM4EGLAGAAALDH1A1 | |
| SCHEMBL1771691 | 0.79 | AR (1.00) | AR | |
| SCHEMBL2795205 | 0.77 | KDM4E (0.67) | KDM4EGLAGAAALDH1A1HPGD | |
| SCHEMBL10743223 | 0.75 | PDE3B (0.55) | ARKDM4EGLAGAAALDH1A1 | |
| SCHEMBL592109 | 0.74 | KDM4E (1.00) | ARKDM4EGLAGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4652221-A1 | HIGH FLOW POLYSTYRENE RESINS, COMPOSITIONS THEREOF AND METHODS OF MAKING | SHPP Global Technologies B.V. (NL) | 2025-11-26 | — | — | EP | claimed |
| EP-4652222-A1 | POLYSTYRENE FOAMS WITH A FLUOROPOLYMER ADDITIVE, COMPOSITIONS THEREOF AND METHODS OF MAKING | SHPP Global Technologies B.V. (NL) | 2025-11-26 | — | — | EP | claimed |
| WO-2024176037-A1 | POLYSTYRENE FOAMS WITH A FLUOROPOLYMER ADDITIVE, COMPOSITIONS THEREOF AND METHODS OF MAKING | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2024-08-29 | — | — | WO | claimed |
| WO-2024176035-A1 | HIGH FLOW POLYSTYRENE RESINS, COMPOSITIONS THEREOF AND METHODS OF MAKING | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2024-08-29 | — | — | WO | claimed |
| EP-4421115-A1 | POLYSTYRENE FOAMS WITH A FLUOROPOLYMER ADDITIVE, COMPOSITIONS THEREOF AND METHODS OF MAKING | SHPP Global Technologies B.V. (NL) | 2024-08-28 | — | — | EP | claimed |
| EP-4421114-A1 | HIGH FLOW POLYSTYRENE RESINS, COMPOSITIONS THEREOF AND METHODS OF MAKING | SHPP Global Technologies B.V. (NL) | 2024-08-28 | — | — | EP | claimed |
| US-11339263-B2 | Fibrillated polymer compositions and methods of their manufacture | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2022-05-24 | — | — | US | claimed |
| US-20260146128-A1 | POLYCARBONATE COMPOSITION, METHOD FOR THE MANUFACTURE THEREOF, AND ARTICLES COMPRISING THE POLYCARBONATE COMPOSITION | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2026-05-28 | — | — | US | disclosed |
| EP-4731711-A2 | LIQUID BINDER COMPOSITIONS AND USES THEREOF | Acs Technical Products, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12612547-B2 | Semiconducting nanoparticle | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-04-28 | — | — | US | disclosed |
| EP-4605473-B1 | POLYCARBONATE COMPOSITION, METHOD FOR THE MANUFACTURE THEREOF, AND ARTICLES COMPRISING THE POLYCARBONATE COMPOSITION | SHPP GLOBAL TECH BV (NL) | 2026-04-01 | — | — | EP | disclosed |
| EP-4232518-B1 | COMPOSITION | SAMSUNG ELECTRONICS CO LTD (KR) | 2026-02-18 | — | — | EP | disclosed |
| EP-4305105-B1 | THERMOPLASTIC COMPOSITIONS | SHPP GLOBAL TECH BV (NL) | 2026-02-18 | — | — | EP | disclosed |
| CN-114174924-A | Negative photosensitive composition containing black colorant | 默克专利有限公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-114174925-A | Negative photosensitive composition | 默克专利有限公司 | 2022-03-11 | — | — | CN | disclosed |
| WO-2022049096-A1 | DEVICE | MERCK PATENT GMBH (DE) | 2022-03-10 | — | — | WO | disclosed |
| US-11269255-B2 | Photosensitive composition and color converting film | MERCK PATENT GMBH (DE) | 2022-03-08 | — | — | US | disclosed |
| CN-114144729-A | Low-temperature curable negative photosensitive composition | 默克专利有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-110511550-B | Polycarbonate composition, molded article comprising the same, and method for producing the article | 高新特殊工程塑料全球技术有限公司 | 2022-02-22 | — | — | CN | disclosed |
| US-20220041839-A1 | COMPOSITIONS INCLUDING A LASER MARKING ADDITIVE AND SYSTEMS AND METHODS OF LASER MARKING THE COMPOSITIONS | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2022-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612547-B2 | Semiconducting nanoparticle | SCO2, NAF1, LBR | AR 828/4885KDM4E 4687/4885GLA 2069/4885 |
| US-20260146128-A1 | POLYCARBONATE COMPOSITION, METHOD FOR THE MANUFACTURE THEREOF, AND ARTICLES COMPRISING THE POLYCARBONATE COMPOSITION | CYP46A1, RPTOR, PCNA | AR 921/4885KDM4E 1448/4885GLA 2559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.